Cytotheryx
Business Services · Minnesota, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2112 15th St NW, Rochester, Minnesota, 5...Phone Number
(712) 722-2767Website
www.cytotheryx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Cytotheryx
Cytotheryx, Inc. is dedicated to creating a future without liver disease by developing a platform technology that produces human liver cells in unprecedented quantity and quality. The company addresses the significant demand for functional liver cells, which is critical for treating various liver diseases and conditions. Their innovative solutions, including a bio-incubator and allogeneic hepatocytes, aim to provide new treatments and therapies to a large patient population. Target clients include healthcare providers, researchers, and organizations involved in liver disease treatment and research.Explore more
Cytotheryx Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cytotheryx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Cytotheryx is spiking on competitors!
Check if Cytotheryx has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Cytotheryx launches new products
Funding: Get notified immidiatlly once Cytotheryx has new funding data
Earning: See what the market has to say on Cytotheryx recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Cytotheryx had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Cytotheryx
Cytotheryx, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Cytotheryx
Find more new buyers
Compare Similar Companies to Cytotheryx
Compare insights from companies similar to Cytotheryx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cytotheryx is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cytotheryx is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cytotheryx.
Cytotheryx financials insights
Gather financial insights about Cytotheryx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Series A
$60M
Cytotheryx Tech Stack
A closer look at the technologies used by Cytotheryx
Most Recent Scoops
Funding
Funding
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Person-Based
Event
Product Marketing, Events, Research & Development, Medical Research, Clinical Operations, Healthcare Technology
Cytotheryx News & Media
Rochester biotech firm raises $60M to fund development of liver disease treatments
Cytotheryx, a growing Rochester biotech firm working on treatments for liver disease, recently received $60 million Series A financing as debt financing of an unreleased amount for real estate and facilities.Cytotheryx Secures Lead Investor for $60M Series A; Confirms Debt Financing to Expand Facilities
/PRNewswire/ -- Cytotheryx, Inc. , a preclinical cell therapy company developing cell-based treatments for liver disease, today announced a lead term sheet...Cytotheryx Announces Exclusive License of In Vivo Hepatocyte Selection Technology from OHSU
Cytotheryx secures exclusive license from OHSU for in vivo hepatocyte selection tech to advance safer, scalable therapies for rare and chronic liver diseases. ROCHESTER, MN, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- Cytotheryx, Inc., a …Cytotheryx, Inc. Announces Suit Against Castle Creek Biosciences, Inc. and Paragon Biosciences, LLC, for Fraud
This litigation is the result of a failure by Castle Creek to make a required multimillion dollar stock redemption after the 2021 acquisition of novavita thera. ROCHESTER, MN, UNITED STATES, January 25, 2024 /EINPresswire.com/ -- Cytotheryx, Inc., a …
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cytotheryx
Sign Up For FreeTo access detailed company insights
Cytotheryx, Inc. is dedicated to creating a future without liver disease by developing a platform technology that produces human liver cells in unprecedented quantity and quality. The company addresses the significant demand for functional liver cells, which is critical for treating various liver diseases and conditions. Their innovative solutions,... Read More
